Tetrahydroharmine

Tetrahydroharmine
Clinical data
Other namesTHH; 1,2,3,4-Tetrahydroharmine; Leptaflorine; 7-Methoxy-1,2,3,4-tetrahydroharman; 7-Methoxy-1-methyl-1,2,3,4-tetrahydro-β-carboline; 7-MeO-THH
Routes of
administration
Oral
Drug classHallucinogen; Oneirogen
ATC code
  • None
Legal status
Legal status
  • AU: S9 (Prohibited substance)
Pharmacokinetic data
Elimination half-life4.7–8.8 hours
Duration of actionUnknown
Identifiers
  • 7-methoxy-1-methyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H16N2O
Molar mass216.284 g·mol−1
3D model (JSmol)
  • CC1C2=C(CCN1)C3=C(N2)C=C(C=C3)OC
  • InChI=1S/C13H16N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-4,7-8,14-15H,5-6H2,1-2H3
  • Key:ZXLDQJLIBNPEFJ-UHFFFAOYSA-N

Tetrahydroharmine (THH), also known as 7-methoxy-1,2,3,4-tetrahydroharman (7-MeO-THH), is a fluorescent indole alkaloid and β-carboline that occurs in the tropical liana species Banisteriopsis caapi. It is an oneirogenic hallucinogen similarly to harmaline. Conversely however, in contrast to other harmala alkaloids, it is very weak as a monoamine oxidase inhibitor (MAOI).